| |
| |
|
| Insider
Information: |
Gross Jane A |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
115,583 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$16,378 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
115,583 |
|
|
| Total
Value |
$16,378 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aptevo Therapeutics Inc. |
APVO |
See Remarks |
2019-03-01 |
109,583 |
2017-02-03 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2023-04-26 |
6,000 |
2023-04-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,135 |
21,793 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-02-03 |
4 |
D |
$1.92 |
$11,370 |
D/D |
(5,922) |
15,871 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,140 |
25,011 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-03-01 |
4 |
D |
$2.02 |
$4,339 |
D/D |
(2,148) |
22,593 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-03-09 |
4 |
D |
$1.80 |
$4,631 |
D/D |
(2,573) |
29,747 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,727 |
32,320 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,506 |
44,253 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-03-10 |
4 |
D |
$1.78 |
$6,830 |
D/D |
(3,837) |
40,416 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-08-01 |
4 |
D |
$1.83 |
$18,439 |
D/D |
(10,076) |
68,433 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2017-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,093 |
78,509 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2018-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,136 |
86,569 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,140 |
95,709 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2018-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,728 |
105,437 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2018-03-09 |
4 |
D |
$3.13 |
$7,143 |
D/D |
(2,282) |
103,155 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2019-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,138 |
112,293 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
See Remarks |
• – – |
2019-03-01 |
4 |
D |
$1.57 |
$4,255 |
D/D |
(2,710) |
109,583 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
